Amarin Corp Plc (AMRN)

[Jamaalish]

Seems like the report was well received by the press.

I'm relieved and encouraged by what I've been able to digest so far.

Can't wait to dig into the ICER report more later on.

I'm trying to focus on what this means to Amarin's negotiations with Medicare, the Veterans Administration, third-party payers, etc. As far as I can tell, it seems pretty positive. The preliminary conclusion in the report was something to the effect of, at the current prices, the drug appears to be cost-effective, with some room to spare. That's a great report to bring to the negotiating table. I'd like to go back to gg's linked article a few days ago where I think the FDA was granting wider latitude to drug companies to communicate with payers ahead of FDA approval.

Would love to know what is being said between all of them now in anticipation of expanded label approval. And I wonder if we'll see an immediate impact on reimbursements.